Picture of NextCell Pharma AB logo

NXTCL NextCell Pharma AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapMomentum Trap

Brief: Nextcell Pharma Says Single Treatment With Protrans Shows Effect Over 5 Yrs

May 28 (Reuters) - NextCell Pharma AB  NXTCL.ST :
    * SINGLE TREATMENT WITH PROTRANS DEMONSTRATES LONG-TERM
THERAPEUTIC EFFECT OVER 5 YEARS
    * NO SERIOUS ADVERSE REACTIONS RELATED TO TREATMENT HAVE
BEEN
REPORTED
    * WILL PRESENT MORE DETAILED RESULTS IN COMING WEEKS
    * PROTRANS TREATED PATIENTS MAINTAINED 57% OF THEIR
ENDOGENOUS
INSULIN PRODUCTION COMPARED TO 15% IN PLACEBO GROUP

Source text for Eikon:  ID:nWkr4FjnVk 
Further company coverage:  NXTCL.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

Recent news on NextCell Pharma AB

See all news